Authors: Nicky de Vrij, Elise Pepermans, Louise Laurijssen, Thao-Thy Pham, Lauren Thijs, Kurt Boonen, Kadrie Ramadan, Ilse Maes, Yetemwork Aleka, Mekibib Kassa, Tigist Mekonnen, Mezgebu… Read More »Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape
Hannah R. Volkman , Leonie de Munter, Jennifer L. Nguyen, Thao M. P. Tran, Marianna itratza,Cátia Marques, Laura Choi, Srinivas Valluri, Jingyan Yang, Andrés Antón, Irma… Read More »Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
Leuven, Belgium and Zeist, The Netherlands, November 19, 2025 – P95 and Julius Clinical today announced that they have merged to form a leading global, full-service… Read More »P95 and Julius Clinical merge to form global, science-led CRO delivering integrated clinical development and real-world evidence
Antwerp – Copenhagen – Oct 22nd 2025: Vaccinopolis, the unique clinical research facility at the University of Antwerp in Belgium, is pleased to announce the… Read More »First Controlled Human Infection study at Vaccinopolis in collaboration with NIVI Research Center and support from Province of Antwerp
Recognition for outstanding work in vaccinology and immunology On Saturday, September 27, VUB professor Damya Laoui received the 2025 GSK Vaccines Prize during the annual… Read More »VUB professor Damya Laoui receives the 2025 GSK Vaccines Prize for research into cancer immunotherapy
Together, the partners aim to enable seamless access to integrated multi–species expertise, focusing on advanced preclinical drug development and automated histopathology services, streamlining preclinical research for both human and veterinary drug development. Diepenbeek and… Read More »InnoSer, Connected-Pathology, and Poulpharm Announce Strategic Partnership to Expand Preclinical and Histopathology Services
Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline. Paris, July 22, 2025. Sanofi today announces it has entered into an agreement to acquire Vicebio Ltd (“Vicebio”), a privately… Read More »Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline
Boende, Democratic Republic of the Congo — The PregInPoxVac research project, an international clinical trial aiming to protect pregnant women, new mothers, and children under… Read More »First infants and pregnant women recruited in mpox vaccine trial in the DRCongo
Medellín, Colombia and Nivelles, Belgium – June 23, 2025 VaxThera, a biotechnology company that produce vaccines and biologics, and Quantoom Biosciences, a full-stack RNA partner… Read More »VaxThera and Quantoom Biosciences Achieve Breakthrough in Poultry Vaccination Against Highly Pathogenic Avian Influenza (HPAI) Using Quantoom’s N-Force Toolbox for saRNA
Leuven, Belgium, June 5, 2025 – AstriVax Therapeutics NV, a clinical stage immunotherapy company developing novel treatments for chronic infections based on its proprietary Launch-iT… Read More »AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology
